Hosted on MSN12mon
Why Is Acorda Therapeutics (ACOR) Stock Down 72% Today?
Acorda Therapeutics (NASDAQ:ACOR) stock is falling hard on Tuesday after the biopharmaceutical company signed a stalking horse asset purchase agreement with Merz Therapeutics. This agreement will ...
pharmaphorum4d
Acorda filed for bankruptcy, and Merz is eyeing its assets
Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Merz. The announcement ...